Results for tag: "Gut Hormone Receptor"

The Gut Hormone Receptor market is a subset of the Anti-Obesity Drugs market, which focuses on the development of drugs that target gut hormone receptors. These receptors are responsible for controlling appetite, satiety, and energy balance, and are therefore important targets for the treatment of obesity. Gut hormone receptor drugs are designed to reduce hunger and increase satiety, leading to weight loss. These drugs are typically administered orally, and can be used in combination with lifestyle changes such as diet and exercise. The Gut Hormone Receptor market is highly competitive, with many companies developing drugs that target these receptors. Some of the major players in the market include Novo Nordisk, Orexigen Therapeutics, Arena Pharmaceuticals, and Vivus. Show Less Read more